CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for... CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for its efforts in developing the adenovirus-based viral vector vaccine and other biologics that address significant medical needs. CanSino Biologics covers a wide range of therapeutic areas, including infectious diseases, cancer, and more, using cutting-edge technology and scientific innovation to enhance preventative healthcare. The company has a prominent role within the pharmaceutical industry, contributing to both domestic and international public health initiatives. CanSino Biologics' products are pivotal in controlling outbreaks and have positioned the company as a significant player in the global vaccine market by providing solutions against various diseases, supporting both community health and preparedness for emerging health threats.
Pending data availability
EU Taxonomy Data missing for CanSino Biologics
We haven’t collected EU Taxonomy data for CanSino Biologics yet, or the company
hasn’t made it publicly available.